Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome

Sena Hwang, Dong Yoeb Shin, Seong Hwan Moon, Eun Jig Lee, Sung Kil Lim, Ok Hwa Kim, Yumie Rhee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Hajdu-Cheney syndrome is a rare, autosomal dominant skeletal dysplasia marked by acro-osteolysis of the distal phalanges and severe osteoporosis. Although there are more than 60 reports published to date, proper treatment and subsequent outcome have been scarce. Herein, we report a progress of anti-resorptive therapy with zoledronic acid, in a woman with Hajdu-Cheney syndrome. Results suggest that anti-resorptive therapy may be important in delaying the progress of osteoporosis and preventing fractures, but not necessarily acro-osteolysis itself.

Original languageEnglish
Pages (from-to)543-546
Number of pages4
JournalYonsei medical journal
Volume52
Issue number3
DOIs
Publication statusPublished - 2011 May 1

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome'. Together they form a unique fingerprint.

  • Cite this